|
PIGX expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.52785999999461E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.70480000000395E-06 |
| Normal-vs-Stage2 |
1.202610E-01 |
| Normal-vs-Stage3 |
2.41179999999064E-05 |
| Normal-vs-Stage4 |
3.52120000046696E-07 |
| Stage1-vs-Stage2 |
3.073500E-02 |
| Stage1-vs-Stage3 |
9.970000E-01 |
| Stage1-vs-Stage4 |
1.891810E-01 |
| Stage2-vs-Stage3 |
6.715700E-02 |
| Stage2-vs-Stage4 |
1.124410E-02 |
| Stage3-vs-Stage4 |
2.731000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.44489999970499E-07 |
| Normal-vs-AfricanAmerican |
1.679210E-01 |
| Normal-vs-Asian |
3.39609995680945E-09 |
| Caucasian-vs-AfricanAmerican |
4.827600E-02 |
| Caucasian-vs-Asian |
1.968040E-02 |
| AfricanAmerican-vs-Asian |
5.996500E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.6630000000002E-05 |
| Normal-vs-Female |
1.83709000000087E-05 |
| Male-vs-Female |
9.884800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.13449999792093E-08 |
| Normal-vs-Age(41-60Yrs) |
3.33320000001081E-06 |
| Normal-vs-Age(61-80Yrs) |
2.184300E-02 |
| Normal-vs-Age(81-100Yrs) |
1.664020E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.111200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.063340E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.790800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.469730E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.644400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.149600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.054200E-01 |
| Classical-VS-Follicular |
2.033100E-04 |
| Classical-VS-Other |
5.641000E-01 |
| Classical-VS-Normal |
4.73279999635423E-08 |
| Tall-VS-Follicular |
4.900500E-03 |
| Tall-VS-Other |
6.314200E-01 |
| Tall-VS-Normal |
1.951840E-04 |
| Follicular-VS-Other |
1.206390E-01 |
| Follicular-VS-Normal |
3.756400E-01 |
| Other-VS-Normal |
8.658400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.436320E-04 |
| Normal-vs-N1 |
1.08919995245316E-09 |
| N0-vs-N1 |
4.175900E-04 |
|
|
